Jiangsu Aidea Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 411.33 million compared to CNY 244.22 million a year ago. Net loss was CNY 81.3 million compared to CNY 124.2 million a year ago.

Basic loss per share from continuing operations was CNY 0.19 compared to CNY 0.3 a year ago.